Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:46 AM UTC
| NCT Number | NCT06273176 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-wildtype |
| Phase | Clinical Trial |
| Target Enrollment | 225 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Erasmus Medical Center |
| Last Updated on CT.gov | February 22, 2024 (Feb 22, 2024) |
As of July 13, 2026: Clinical trial NCT06273176 is currently recruiting participants. This clinical trial study for glioblastoma, idh-wildtype is actively seeking new participants at 2 locations across the United States. The study is sponsored by Erasmus Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06273176 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06273176 was last updated Feb 22, 2024 (February 22, 2024). HelloStudys verifies this status automatically.